<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260627069963N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-07-04</date_registration>
      <primary_sponsor>Kerman University of Medical Sciences</primary_sponsor>
      <public_title>The effect of therapeutic touch and virtual reality on pain intensity, anxiety level, and satisfaction in patients requiring sutures.</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the Effect of Touch Therapy and Virtual Reality on Pain Intensity, Anxiety Level, and Satisfaction in Patients Requiring Sutures Referred to the Emergency Department</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-06-29</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>81</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/91235</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: N/A, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Blinding description: In this study, blinding of participants is not feasible due to the nature of the interventions (touch therapy and virtual reality). Touch therapy requires the patient's awareness of physical contact, and virtual reality is clearly distinguishable; moreover, the use of a sham intervention (e.g., neutral content) would not completely mislead the patient. To mitigate assessment bias, statistical blinding will be employed, whereby the data analyst remains unaware of group allocation, allowing the results to be examined without prejudice.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Patients Requiring Sutures.</hc_freetext>
      <i_freetext>Intervention 1: Control group: This group receives routine emergency care. In standard care, the emergency physician, after local anesthesia with 2% lidocaine (based on wound size and patient weight) and wound examination, performs wound closure in a minor procedure room. Patients have the opportunity to request additional local anesthesia during the procedure. All simple laceration suturing will be performed by the emergency physician. A simple laceration refers to a skin tear that does not involve nerves, tendons, arteries, veins, or bones. Before suturing and intervention, patients are placed in an appropriate position. To ensure maximum consistency of conditions, all patients will be placed in a supine position under suitable conditions before and after the intervention. Routine care provided to all patients includes the following: initially, the wound and the area to be sutured are irrigated with 0.9% normal saline by an experienced emergency operating room nurse. The emergency physician's hands are washed using the proper technique and sterile gloves are worn. All required equipment, including syringes, local anesthetic, suture needles and threads, and suture sets, are prepared and placed sterilely on the tray. Lidocaine 2% without epinephrine (based on wound size and patient weight, with a maximum dose of 4.5 cc/kg) is used for anesthesia of the suture site. The syringe is filled using a sterile technique, and a 25G or 27G needle is selected according to the injection site. For anesthetic injection, the emergency physician first disinfects the skin of the target area again with Hexaspet or alcohol antiseptic solution, then the pre-filled syringe is gently inserted into the dermal area at a 10-15 degree angle, and lidocaine is injected gradually. Injection is performed in a parallel manner around the wound and its edges to ensure complete anesthesia of the entire area. After injection, 3-5 minutes are allowed for the anesthetic to take full effect, then the wound is examined, and if suturing is required, it is performed by an experienced emergency physician. For simple interrupted sutures, a sterile reverse-cutting curved needle with 4-0 nylon suture material is selected. The needle is inserted into the skin at an appropriate depth and angle according to the suture site, maintaining a distance of approximately 3-5 mm from the wound edge. The needle is passed in a curved manner from one side of the wound and exits from the other side at the same distance from the wound edge (ensuring equal depth of entry and exit). The suture is then pulled to approximate the wound edges. Finally, simple knots are tied (5-6 simple knots) and the suture ends are cut to an appropriate length. This process is repeated for each suture individually. For vertical mattress sutures, the needle is inserted approximately 4-6 mm from the wound edge and exits from the opposite side at the same distance from the wound edge. The needle is then reinserted approximately 1-2 mm from the wound edge and exits from the opposite side at the same distance. The suture is pulled to approximate the wound edges, and then 4-6 simple knots are tied and secured. Finally, the suture ends are cut to an appropriate length. This process is repeated for each suture individually. Throughout the study, every effort will be made to ensure that all procedures are performed by the same physician and the same nurse. Intervention 2: Intervention group: First Intervention Group – Touch Therapy by Patient's Companion Among the patient's companions, the one who has the closest relationship and attachment to the patient and has no mental health issues will be selected if willing to participate in the intervention. A 3-minute instructional video is shown to the companion, followed by in-person practical training. The training content includes: 1) introduction to the basic principles of touch therapy and its benefits in reducing pain and anxiety; 2) training in standard touch therapy techniques; 3) emphasis on avoiding direct pressure on the wound or painful areas; and 4) observance of ethical principles (respecting the patient's privacy and obtaining verbal consent during performance).After training completion, the companion sits beside the patient's bed and a calm environment is established (reducing light and ambient noise when possible). The patient is asked to close their eyes and practice deep breathing. Then, the companion gently takes the patient's hands and performs touch therapy during suturing with gentle, rhythmic movements (such as stroking the back of the hand or massaging the palm) according to the following steps: Hand Massage Steps:    First Touch (Gentle Rhythmic Pressure): Using the fingertips, gentle rhythmic pressure is applied to the thenar eminence, the base of the index finger, the webbing between fingers, and the fleshy part of the palm (palmar surface).    Second Touch (Compressive-Rotatory Touch): Using the thumb and index finger eminences, compressive touch with a twisting motion (similar to gentle squeezing and kneading) is applied from the base to the tip of each of the patient's fingers.    Third Touch (Circular Massage): While the patient's palm is supported by the companion's palm, the back of the patient's hand and fingers are massaged in a circular motion with the other palm. The researcher indirectly monitors the correct execution of the touch from an appropriate distance, and in case of errors, the intervention is corrected or stopped. Intervention 3: Intervention group: Second Intervention Group – Virtual Reality              VRG (virtual reality glasses) are devices that work with compatible smartphones. They can be used to watch videos taken at a 360‑degree angle, and any type of wired headphones can be connected to the audio output. Observing relaxing images along with soothing music through VRG during invasive procedures such as suturing allows patients to embark on an imaginary journey that distances them from the clinic where they are surrounded by medical equipment and leads them to a calmer environment. It is believed that the use of VRG increases the secretion of endorphins and oxytocin while reducing adrenaline levels, thus inducing physical relaxation. This technology can be used as a non‑invasive and effective method for pain relief. This approach was selected because studies using VRG have demonstrated that it is an efficient method for pain management. A video depicting a natural environment along with music featuring nature sounds is shown to patients in the VRG intervention group for 5 minutes prior to anesthetic injection and during wound repair by suturing. Headphones are used to listen to recorded music that plays nature sounds. The glasses are placed on the patient's eyes before suturing begins and are not removed during wound repair. The aim is for patients to observe nature more effectively and listen to its sounds, allowing them to focus on the images and sounds and distract themselves from the stress of the current environment. The same video was shown to each patient, and the glasses were disinfected after each use. Regarding the equipment used, a VR headset with high resolution and a wide field of view (at least 100 degrees) was used, and the designed content includes relaxing environments such as seashore, forest, and green spaces with nature sound effects. The patient will be positioned in a semi‑recumbent or supine position on the emergency bed. Ambient lighting will be adjusted and distracting noises minimized. The use of the headset will be explained to the patient, and the patient will also be assured that if they experience dizziness or discomfort, they may remove the device. Regarding the intervention protocol, five minutes before suturing begins, the headset is placed on the patient's head and the necessary adjustments are made for comfort. The patient is immersed in the virtual environment for the duration of the suturing, noting that the VR content is 10 minutes long and is replayed if needed. During the intervention, the researcher remains beside the patient to assist if necessary. After the intervention is completed, the headset is removed from the patient's head, and the patient is then given 2‑3 minutes to re‑adapt to the real environment.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is No further information is available.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Roghayeh Mehdipour Rabori</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Haft Bagh-e Alavi Axis (Beginning), Kerman University of Medical Sciences Campus, Kerman</address>
        <city>Kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7616913555</zip>
        <telephone>+98 34 3132 5194</telephone>
        <email>r_Mhdipour@kmu.ac.ir</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Roghayeh Mehdipour Rabori</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Haft Bagh-e Alavi Axis (Beginning), Kerman University of Medical Sciences Campus, Kerman</address>
        <city>Kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7616913555</zip>
        <telephone>+98 34 3132 5194</telephone>
        <email>r_Mhdipour@kmu.ac.ir</email>
        <affiliation>Kerman University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>At least 18 years of age
Alert and oriented to time, place, and person
Patients with lacerations at least 2 cm in length that require suturing for wound closure
No use of anxiolytics or analgesics within 12 hours prior to the study
No tendon or ligament rupture
No severe psychiatric disorders (e.g., psychotic disorders, schizophrenia, post‑traumatic stress disorder, major depressive disorder, etc.)
Patients whose suturing is performed using 4‑0 nylon suture with a reverse‑cutting needle.
The suturing technique used is either simple interrupted or vertical mattress</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Visual, hearing, speech, or physical disability and paralysis
Having a rheumatologic disease and undergoing medical treatment
Lacerations resulting from self‑harm
Multiple lacerations and concurrent injury to other organs
Opioid addiction
Patients with a history of senile dementia, seizure disorder, motion sickness, or any condition that affects tactile perception.
Patients with lacerations on the head or face that would interfere with placement of the virtual reality headset.
Patients who had injury or infection above the neck
Erythema, edema, fracture, pain, or abnormality in the hands, as well as other conditions affecting the hands (e.g., phlebitis, diabetes mellitus, neurological disorders)
Patients who have received massage or other relaxation interventions (e.g., music therapy) within the past week</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: This group receives routine emergency care. In standard care, the emergency physician, after local anesthesia with 2% lidocaine (based on wound size and patient weight) and wound examination, performs wound closure in a minor procedure room. Patients have the opportunity to request additional local anesthesia during the procedure. All simple laceration suturing will be performed by the emergency physician. A simple laceration refers to a skin tear that does not involve nerves, tendons, arteries, veins, or bones. Before suturing and intervention, patients are placed in an appropriate position. To ensure maximum consistency of conditions, all patients will be placed in a supine position under suitable conditions before and after the intervention. Routine care provided to all patients includes the following: initially, the wound and the area to be sutured are irrigated with 0.9% normal saline by an experienced emergency operating room nurse. The emergency physician's hands are washed using the proper technique and sterile gloves are worn. All required equipment, including syringes, local anesthetic, suture needles and threads, and suture sets, are prepared and placed sterilely on the tray. Lidocaine 2% without epinephrine (based on wound size and patient weight, with a maximum dose of 4.5 cc/kg) is used for anesthesia of the suture site. The syringe is filled using a sterile technique, and a 25G or 27G needle is selected according to the injection site. For anesthetic injection, the emergency physician first disinfects the skin of the target area again with Hexaspet or alcohol antiseptic solution, then the pre-filled syringe is gently inserted into the dermal area at a 10-15 degree angle, and lidocaine is injected gradually. Injection is performed in a parallel manner around the wound and its edges to ensure complete anesthesia of the entire area. After injection, 3-5 minutes are allowed for the anesthetic to take full effect, then the wound is examined, and if suturing is required, it is performed by an experienced emergency physician. For simple interrupted sutures, a sterile reverse-cutting curved needle with 4-0 nylon suture material is selected. The needle is inserted into the skin at an appropriate depth and angle according to the suture site, maintaining a distance of approximately 3-5 mm from the wound edge. The needle is passed in a curved manner from one side of the wound and exits from the other side at the same distance from the wound edge (ensuring equal depth of entry and exit). The suture is then pulled to approximate the wound edges. Finally, simple knots are tied (5-6 simple knots) and the suture ends are cut to an appropriate length. This process is repeated for each suture individually. For vertical mattress sutures, the needle is inserted approximately 4-6 mm from the wound edge and exits from the opposite side at the same distance from the wound edge. The needle is then reinserted approximately 1-2 mm from the wound edge and exits from the opposite side at the same distance. The suture is pulled to approximate the wound edges, and then 4-6 simple knots are tied and secured. Finally, the suture ends are cut to an appropriate length. This process is repeated for each suture individually. Throughout the study, every effort will be made to ensure that all procedures are performed by the same physician and the same nurse.</i_keyword>
      <i_keyword>Intervention group: First Intervention Group – Touch Therapy by Patient's Companion Among the patient's companions, the one who has the closest relationship and attachment to the patient and has no mental health issues will be selected if willing to participate in the intervention. A 3-minute instructional video is shown to the companion, followed by in-person practical training. The training content includes: 1) introduction to the basic principles of touch therapy and its benefits in reducing pain and anxiety; 2) training in standard touch therapy techniques; 3) emphasis on avoiding direct pressure on the wound or painful areas; and 4) observance of ethical principles (respecting the patient's privacy and obtaining verbal consent during performance).After training completion, the companion sits beside the patient's bed and a calm environment is established (reducing light and ambient noise when possible). The patient is asked to close their eyes and practice deep breathing. Then, the companion gently takes the patient's hands and performs touch therapy during suturing with gentle, rhythmic movements (such as stroking the back of the hand or massaging the palm) according to the following steps: Hand Massage Steps:    First Touch (Gentle Rhythmic Pressure): Using the fingertips, gentle rhythmic pressure is applied to the thenar eminence, the base of the index finger, the webbing between fingers, and the fleshy part of the palm (palmar surface).    Second Touch (Compressive-Rotatory Touch): Using the thumb and index finger eminences, compressive touch with a twisting motion (similar to gentle squeezing and kneading) is applied from the base to the tip of each of the patient's fingers.    Third Touch (Circular Massage): While the patient's palm is supported by the companion's palm, the back of the patient's hand and fingers are massaged in a circular motion with the other palm. The researcher indirectly monitors the correct execution of the touch from an appropriate distance, and in case of errors, the intervention is corrected or stopped</i_keyword>
      <i_keyword>Intervention group: Second Intervention Group – Virtual Reality              VRG (virtual reality glasses) are devices that work with compatible smartphones. They can be used to watch videos taken at a 360‑degree angle, and any type of wired headphones can be connected to the audio output. Observing relaxing images along with soothing music through VRG during invasive procedures such as suturing allows patients to embark on an imaginary journey that distances them from the clinic where they are surrounded by medical equipment and leads them to a calmer environment. It is believed that the use of VRG increases the secretion of endorphins and oxytocin while reducing adrenaline levels, thus inducing physical relaxation. This technology can be used as a non‑invasive and effective method for pain relief. This approach was selected because studies using VRG have demonstrated that it is an efficient method for pain management. A video depicting a natural environment along with music featuring nature sounds is shown to patients in the VRG intervention group for 5 minutes prior to anesthetic injection and during wound repair by suturing. Headphones are used to listen to recorded music that plays nature sounds. The glasses are placed on the patient's eyes before suturing begins and are not removed during wound repair. The aim is for patients to observe nature more effectively and listen to its sounds, allowing them to focus on the images and sounds and distract themselves from the stress of the current environment. The same video was shown to each patient, and the glasses were disinfected after each use. Regarding the equipment used, a VR headset with high resolution and a wide field of view (at least 100 degrees) was used, and the designed content includes relaxing environments such as seashore, forest, and green spaces with nature sound effects. The patient will be positioned in a semi‑recumbent or supine position on the emergency bed. Ambient lighting will be adjusted and distracting noises minimized. The use of the headset will be explained to the patient, and the patient will also be assured that if they experience dizziness or discomfort, they may remove the device. Regarding the intervention protocol, five minutes before suturing begins, the headset is placed on the patient's head and the necessary adjustments are made for comfort. The patient is immersed in the virtual environment for the duration of the suturing, noting that the VR content is 10 minutes long and is replayed if needed. During the intervention, the researcher remains beside the patient to assist if necessary. After the intervention is completed, the headset is removed from the patient's head, and the patient is then given 2‑3 minutes to re‑adapt to the real environment.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain intensity. Timepoint: The questionnaires are administered by the researcher via direct questioning of the patient, five minutes before local anesthesia and suturing, and are completed once more after the suturing procedure. Method of measurement: Visual analog scale.</prim_outcome>
      <prim_outcome>Anxiety level. Timepoint: The questionnaires are administered by the researcher via direct questioning of the patient, five minutes before local anesthesia and suturing, and are completed once more after the suturing procedure. Method of measurement: Spielberg State-Trait Anxiety Inventory.</prim_outcome>
      <prim_outcome>Satisfaction. Timepoint: After the suturing is completed. Method of measurement: Visual Analog Scale for Satisfaction.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kerman University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-01-11</approval_date>
        <contact_name>Ethics committee of Kerman University of Medical Sciences</contact_name>
        <contact_address>Aria Building, 7th Alley, Imam Hassan Boulevard, Kerman, Iran Kerman Kerman Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
